Riskpilot← Back to searchSign inGet full accessProvivus AB
ABActiveOrg 5567398424Krukmakargatan 8Other education n.e.c. · NACE 8559Est. 20071 employees
Revenue 2025
SEK 415K
+371% vs 2024
EBITDA margin
89.9%
+417% vs 2024
Equity ratio
77.8%
Financial strength
Net profit 2025
SEK 290K
+434% vs 2024
| Revenue | SEK 415K | +371% |
| EBITDA | SEK 373K | +417% |
| Net profit | SEK 290K | +434% |
| Total assets | SEK 1,2M | +7% |
| Equity | SEK 905K | +18% |
| Employees | 1 | — |
Legal name
Provivus AB
Org number
5567398424
Legal form
Aktiebolag
NACE code
8559 · Other education n.e.c.
Founded
12 oktober 2007
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva utbildning, utveckling av individ, grupp och organisation, psykologisk och pedagogisk handledning och konsultation och vård (föräldrastöd, psykologutredning, elevhälsovård) samt därmed förenlig verksamhet.
Address
Krukmakargatan 8
Email
david.edfelt@provivus.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 46 | 480 | 976 | 88 | 415 |
| Staff expenses | — | −11 | −20 | −1 | −2 |
| EBITDA | −20 | 418 | 914 | 72 | 373 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | −20 | 418 | 914 | 72 | 373 |
| Net financials | — | −0 | −1 | −2 | −5 |
| Profit before tax | −20 | 418 | 683 | 70 | 368 |
| Tax | −0 | −74 | −142 | −16 | −78 |
| Net profit | −20 | 344 | 541 | 54 | 290 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 131 | 661 | 1 169 | 1 085 | 1 163 |
| Equity | 125 | 469 | 710 | 765 | 905 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 6 | 192 | 229 | 90 | 28 |
| Total debt | 6 | 192 | 229 | 90 | 28 |
EBITDA margin
89.9%
This company
15.8%
Market median
+469% vs market
20212025
Equity ratio
77.8%
This company
38.2%
Market median
+104% vs market
20212025
Return on equity
32.1%
This company
18.4%
Market median
+74% vs market
20212025
Net profit margin
69.9%
This company
8.1%
Market median
+763% vs market
20212025
Asset turnover
0.36×
This company
1.12×
Market median
-68% vs market
20212025
Debt / equity
0.29×
This company
0.62×
Market median
+53% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2020 | |
| Board of Directors | 2020 | |
| Former (3) | ||
| Deputy Board Member | 2021 – 2022 | |
| Board of Directors | 2020 – 2022 | |
| Deputy Board Member | 2020 – 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Provivus AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Miriam Anna Hartstein | Deputy Board Member | 0 companies |
| David Johan Edfelt | Board of Directors | 0 companies |
| Axel Simon Frank Kendall | Deputy Board Member | 0 companies |
| Gunilla Maria E Carlsson Kendall | Board of Directors | 0 companies |
| David Frank Kendall | Deputy Board Member | 0 companies |